The world's largest drugmakers recently received some good news. A new class of diabetes drugs was found not to increase the risk of heart attack and stroke - deadly side effects which have plagued some older diabetes treatments.
A new study in the New England Journal of Medicine suggests that we may be getting better at treating heart attacks.
Some doctors will recommend surgery to fix the meniscal tear while others will recommend a more conservative approach with physical therapy.
When Sgt. 1st Class Jamie Menard deploys from Fort Gordon, the entire Menard family, which has endured four deployments in 10 years, becomes afraid for the worst.
All too often for people like Sheryl Redman, particularly in the South, cost is a barrier to getting care particularly in states with restrictive Medicaid eligibility, a study published Thursday finds.
NEW YORK - It's dramatic news when a marathon runner collapses with no pulse. Now a big study finds such calamities are rare and usually due to a pre-existing heart problem.
As criticism of sugary sodas intensifies, Coke, Pepsi and Dr Pepper are rolling out new vending machines that will put calorie counts right at your fingertips.
It seemed to come out of nowhere in April, when it was diagnosed in two unrelated children in California.
This effort diverts us from the real issue at hand -- affordable, attainable and safe health care.
ATLANTA --- Four years after the government severely restricted its use, the lung cancer drug Iressa may be poised to make a comeback: A study concludes it can slow the deadly disease better than standard chemotherapy in certain patients.